P06213 (INSR_HUMAN) Homo sapiens (Human)

Insulin receptor UniProtKBInterProSTRINGInteractive Modelling

1382 aa; Sequence (Fasta) ; (Isoform 2; )

Molecule Processing
Insulin receptor subunit alpha
Insulin receptor subunit beta

Sequence Features

Add
 1159Proton donor/acceptor
 66Insulin-binding
 551Interchain
 2A -> G (in dbSNP:rs7508518) VAR_058395 dbSNP
 42N -> K (in RMS; impairs transport to the plasma membrane and reduces the affinity to bind insulin; dbSNP:rs121913143) VAR_004079 dbSNP
 55V -> A (in LEPRCH; Verona-1; dbSNP:rs121913152) VAR_004080 dbSNP
 56I -> T (in LEPRCH; abolishes post-translational processing; dbSNP:rs1555689937) VAR_079535 dbSNP
 58G -> R (in LEPRCH; Helmond; inhibits processing and transport; dbSNP:rs52836744) VAR_004081 dbSNP
 86D -> G (in IRAN type A) VAR_015907
 89L -> P (in IRAN type A) VAR_015908
 113R -> P (in LEPRCH; Atlanta-1; abolishes insulin binding; dbSNP:rs121913153) VAR_004082 dbSNP
 119A -> V (in LEPRCH; markedly impairs insulin binding; dbSNP:rs1347473020) VAR_015909 dbSNP
 120L -> Q (in LEPRCH; inhibits receptor processing) VAR_031518
 146I -> M (in LEPRCH; mild; dbSNP:rs121913159) VAR_015539 dbSNP
 167V -> L (in IRAN type A; dbSNP:rs938519025) VAR_015910 dbSNP
 171Y -> H (in dbSNP:rs1051692) VAR_058396 dbSNP
 220P -> L (in Ins resistance; severe; dbSNP:rs749094324) VAR_004083 dbSNP
 228C -> R (in a gastric adenocarcinoma sample; somatic mutation) VAR_041429
 236H -> R (in RMS and LEPRCH; Winnipeg; may impair receptor processing; dbSNP:rs121913145) VAR_004084 dbSNP
 256R -> C (in RMS; dbSNP:rs781007453) VAR_079536 dbSNP
 260L -> P (in LEPRCH; Geldeimalsen; dbSNP:rs121913141) VAR_004085 dbSNP
 279R -> C (in IRAN type A; inhibits receptor internalization; dbSNP:rs1568470274) VAR_015540 dbSNP
 279R -> H (in IRAN type A; interferes with receptor processing; dbSNP:rs1329693158) VAR_031519 dbSNP
 280C -> Y (in IRAN type A) VAR_015911
 286C -> Y (in LEPRCH; abolishes post-translational processing) VAR_079537
 301C -> Y (in LEPRCH) VAR_015912
 308Missing (in LEPRCH; abolishes insulin binding) VAR_015913
 350S -> L (in RMS and LEPRCH) VAR_015914
 362Missing (in LEPRCH) VAR_015541
 386G -> S (in RMS; may impair receptor processing; dbSNP:rs764221583) VAR_031520 dbSNP
 393G -> R (in LEPRCH; Verona-1; dbSNP:rs267607184) VAR_004086 dbSNP
 409F -> V (in IRAN type A; dbSNP:rs121913142) VAR_004087 dbSNP
 439W -> S (in LEPRCH; impairs transport of the receptor to the cell surface; dbSNP:rs121913158) VAR_015542 dbSNP
 448I -> T (in dbSNP:rs1051691) VAR_015915 dbSNP
 458N -> D (in LEPRCH; partially inhibits receptor processing and autophosphorylation; strongly impairs ERK phosphorylation; induces wild-type levels of IRS-1 phosphorylation; dbSNP:rs121913160) VAR_031521 dbSNP
 487K -> E (in LEPRCH; ARK-1; dbSNP:rs121913136) VAR_004088 dbSNP
 489N -> D (in IRAN type A; unknown pathological significance; dbSNP:rs1135401742) VAR_079538 dbSNP
 489N -> S (in IRAN type A; dbSNP:rs121913147) VAR_004089 dbSNP
 492Q -> K VAR_015916
 635S -> L (in RMS; decreases post-translational processing) VAR_079539
 657V -> F (in LEPRCH; impairs post-translational processing; dbSNP:rs1135401737) VAR_079540 dbSNP
 659W -> R (in LEPRCH; impairs post-translational processing) VAR_079541
 695Q -> R (in dbSNP:rs55906835) VAR_041430 dbSNP
 762R -> S (in IRAN type A; dbSNP:rs121913138) VAR_004090 dbSNP
 811G -> S (in dbSNP:rs35045353) VAR_041431 dbSNP
 818Y -> C (in LEPRCH; abolishes post-translational processing) VAR_079542
 830P -> L (in dbSNP:rs2162771) VAR_055986 dbSNP
 835S -> I (in RMS; impairs post-translational processing; dbSNP:rs1135401739) VAR_079543 dbSNP
 842A -> V (in RMS; decreases post-translational processing; dbSNP:rs1135401738) VAR_079544 dbSNP
 858T -> A (in NIDDM; dbSNP:rs182552223) VAR_015917 dbSNP
 874P -> L (in RMS; impairs post-translational processing) VAR_079545
 878N -> S (in RMS; impairs post-translational processing; dbSNP:rs887190835) VAR_079546 dbSNP
 925I -> T (in LEPRCH; abolishes post-translational processing; abolishes insulin binding; dbSNP:rs1599881881) VAR_015918 dbSNP
 926R -> W (in LEPRCH; markedly impairs insulin binding;impairs post-translational processing; dbSNP:rs911929963) VAR_015919 dbSNP
 937T -> M (in LEPRCH; impaired receptor processing; impairs post-translational processing) VAR_015920
 997P -> T (in RMS; reduces insulin binding) VAR_015921
 1012V -> M (in dbSNP:rs1799816) VAR_004091 dbSNP
 1020R -> Q (in IRAN type A; dbSNP:rs121913148) VAR_004092 dbSNP
 1023I -> F VAR_015922
 1035G -> V (in IRAN type A; dbSNP:rs121913135) VAR_004093 dbSNP
 1054V -> M (in IRAN type A; unknown pathological significance; dbSNP:rs1135401741) VAR_079549 dbSNP
 1055A -> V (in IRAN type A; dbSNP:rs1599874183) VAR_015923 dbSNP
 1065L -> V (in dbSNP:rs56395521) VAR_041432 dbSNP
 1075A -> D (in IRAN type A) VAR_004094
 1095K -> E (in a NIDDM subject; dbSNP:rs909008899) VAR_015924 dbSNP
 1119R -> W (in LEPRCH; dbSNP:rs1229730671) VAR_015925 dbSNP
 1143I -> T (in RMS; reduces insulin binding) VAR_015926
 1158R -> Q (in NIDDM) VAR_015927
 1158R -> W (in RMS; abolishes insulin binding; dbSNP:rs111993466) VAR_015928 dbSNP
 1161A -> T (in IRAN type A; dbSNP:rs121913139) VAR_004095 dbSNP
 1162A -> E (in IRAN type A; impairs proteolytic processing; dbSNP:rs121913154) VAR_004096 dbSNP
 1180M -> I (in a patient with insulin resistance; dbSNP:rs121913157) VAR_004097 dbSNP
 1191R -> Q (in NIDDM; dbSNP:rs121913150) VAR_004098 dbSNP
 1201R -> Q (in HHF5 and IRAN type A; interferes with kinase activation by insulin; dbSNP:rs121913156) VAR_015929 dbSNP
 1201R -> W (in LEPRCH and RMS; reduces insulin binding possibly due to reduced receptor levels on the cell surface; dbSNP:rs1568426700) VAR_015930 dbSNP
 1205P -> L (in IRAN type A; moderate; dbSNP:rs1295645322) VAR_004099 dbSNP
 1206E -> D (in IRAN type A; accelerates degradation of the protein and impairs kinase activity) VAR_015931
 1206E -> K (in LEPRCH) VAR_015932
 1220W -> L (in IRAN type A; accelerates degradation of the protein and impairs kinase activity; dbSNP:rs52800171) VAR_004100 dbSNP
 1227W -> S (in IRAN type A; dbSNP:rs121913140) VAR_004101 dbSNP
 1282T -> A (in dbSNP:rs55875349) VAR_041433 dbSNP
 1361Y -> C (in dbSNP:rs13306449) VAR_015933 dbSNP
 1378R -> Q (in IRAN type A; dbSNP:rs52826008) VAR_015934 dbSNP
 957-979Helical
 1104-1110ATP
 1163-1164ATP
 35-53
 153-182
 186-209
 196-215
 219-228
 223-234
 235-243
 239-252
 255-264
 268-280
 286-311
 293-301
 315-328
 331-335
 339-360
 462-495
 674-899
 825-834
 890-1382Missing (in LEPRCH) VAR_079547
 999-1382Missing (in RMS) VAR_079548
 52-163Receptor L-domain
IPR000494PF01030
 179-340Furin-like cysteine-rich domain
IPR006211PF00757
 359-469Receptor L-domain
IPR000494PF01030
 940-987Insulin receptor, trans-membrane domain
IPR040969PF17870
 1024-1290Serine-threonine/tyrosine-protein kinase, catalytic domain
IPR001245PF07714

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRange
human insulin receptor ectodomain bound by 4 insulin Heteromer
P01308;
6sof28-956
Assess
Structure of the human insulin receptor ectodomain, IRDeltabeta construct, in complex with four Fab… Heteromer
NAG;NAG;NAG;NAG;NAG;4zxb28-949
Assess
Cryo-EM structure of full-length insulin receptor bound to 4 insulin. 3D refinement was focused on … Heteromer
A6XGL2;
6pxv28-949
Assess
Cryo-EM Structure for the Ectodomain of the Full-length Human Insulin Receptor in Complex with 2 In… Heteromer
P01308;
7bwa32-852
Assess
Cryo-EM Structure for the Ectodomain of the Full-length Human Insulin Receptor in Complex with 1 In… Heteromer
P01308;
7bw732-852
Assess
Insulin Receptor ectodomain in complex with two insulin molecules - C1 symmetry Heteromer
P01308; P01318;
NAG;NAG;NAG;NAG;NAG;6ceb28-847
Assess
Insulin Receptor ectodomain in complex with one insulin molecule Heteromer
P01308; P01318;
6ce728-847
Assess
Leucine-zippered human insulin receptor ectodomain with single bound insulin - "upper" membrane-dis… Heteromer
P01308;
NAG;NAG;6hn528-757
Assess
Insulin Receptor ectodomain in complex with two insulin molecules Heteromer
P01308; P01318;
NAG;NAG;NAG;NAG;NAG;6ce928-746
Assess
Cryo-EM structure of full-length insulin receptor bound to 4 insulin. 3D refinement was focused on … Heteromer
A6XGL2;
6pxw28-744
Assess
Human insulin in complex with the human insulin microreceptor in turn in complex with Fv 83-7 Heteromer
P01308;
NAG;NAG;NAG;6vep31-746
Assess
Con-Ins G1 in complex with the human insulin microreceptor in turn in complex with Fv 83-7 Heteromer
A0A0B5A8Q2; A0A0B5AC95;
NAG;NAG;NAG;SO4;6veq32-746
Assess
Insulin in complex with Site 1 of the human insulin receptor Heteromer
P01308;
NAG;NAG;NAG;4oga32-746
Assess
Cryo-EM Structure for the Insulin Binding Region in the Ectodomain of the Full-length Human Insulin… Heteromer
P01308;
7bw832-744
Assess
Insulin receptor ectodomain construct comprising domains L1-CR in complex with human insulin, Alpha… Heteromer
P01308;
NAG;NAG;NAG;3w1132-742
Assess
Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insuli… Heteromer
P01308;
NAG;NAG;NAG;3w1232-742
Assess
Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insuli… Heteromer
P01308;
NAG;NAG;NAG;3w1332-742
Assess
Insulin receptor ectodomain construct comprising domains L1,CR,L2, FnIII-1 and alphaCT peptide in c… Heteromer
P01317;
NAG;NAG;5kqv28-620
Assess
Insulin-like growth factor I in complex with site 1 of a hybrid insulin receptor / Type 1 insulin-l… Heteromer
P05019; P08069;
NAG;NAG;SO4;NAG;4xss28-336
Assess
Structure of the endoglycosidase-H treated L1-CR domains of the human insulin receptor in complex w… Heteromer
P15127;
NAG;NAG;SO4;4xst32-336
Assess
Crystal structure of the Grb14 BPS region in complex with the insulin receptor tyrosine kinase Heteromer
Q14449;
CA;2auh1011-1310
Assess
Phosphorylated insulin receptor tyrosine kinase in complex with (4-{[5-carbamoyl-4-(3-methylanilino… Heteromer
P35568;
S91;2z8c1011-1310
Assess
Human insulin receptor domains L1-CR in complex with peptide S519C16 and 83-7 Fv Heteromer
NAG;NAG;NAG;NAG;5j3h32-330
Assess
Crystal structure of the insulin receptor kinase in complex with IRS2 KRLB peptide Heteromer
P81122;
3bu31014-1310
Assess
Crystal structure of the insulin receptor kinase in complex with IRS2 KRLB phosphopeptide Heteromer
P81122;
3bu61014-1310
Assess
Crystal structure of the insulin receptor kinase in complex with IRS2 KRLB peptide and ATP Heteromer
P81122;
MG;ATP;3bu51014-1310
Assess
Crystal structure of a complex between PTP1B and the insulin receptor tyrosine kinase Heteromer
P18031;
10×SO4;2b4s1014-1310
Assess
Crystal Structure of the Insulin Receptor Kinase in Complex with the SH2 Domain of APS Heteromer
Q9Z200;
MN;112;1rqq1014-1310
Assess
Structure of the IRS-1 PTB Domain Bound to the Juxtamembrane Region of the Insulin Receptor Heteromer
P35568;
5u1m991-999
Assess
Leucine-zippered human insulin receptor ectodomain with single bound insulin - "lower" membrane-pro…homo-2-mer NAG;6hn431-946
Assess
Insulin receptor (domains 1-3)homo-2-mer NAG;NAG;NAG;NAG;NAG;NAG;NAG;SO4;P33; 19×GOL;2hr731-497
Assess
Crystal structure of the activated insulin receptor tyrosine kinase dimerhomo-2-mer ACP;MG;4xlv1001-1310
Assess
PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH PEPTIDE SUBSTRATE AND ATP ANALOGhomo-2-mer MG;ANP;1ir31008-1310
Assess
Crystal structure of insulin receptor kinase domain in complex with cis-(R)-7-(3-(azetidin-1-ylmeth…monomer 60O;EDO;5hhw1005-1310
Assess
Crystal structure of a catalytic-loop mutant of the insulin receptor tyrosine kinasemonomer 1p141005-1310
Assess
Insulin receptor kinase complexed with an inhibitormonomer GS2;3ekk1007-1309
Assess
CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HUMAN INSULIN RECEPTORmonomer EMC;1irk1008-1310
Assess
CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH A BISUBSTRATE INHIBITORmonomer MG;112;1gag1008-1310
Assess
Crystal structure of insulin receptor kinase domain in complex with an inhibitor Irfin-1monomer IR1;4ibm1009-1309
Assess
The Crystal structure of INSR Tyrosine Kinase in complex with the Inhibitor BI 885578monomer 5JA;5e1s1010-1310
Assess
Insulin receptor kinase complexed with an inhibitormonomer GS3;3ekn1011-1310
Assess
CRYSTALLOGRAPHIC STUDIES OF AN ACTIVATION LOOP MUTANT OF THE INSULIN RECEPTOR TYROSINE KINASEmonomer MG;ACP;1i441013-1310
Assess
Kinase domain of insulin receptor complexed with a pyrrolo pyridine inhibitormonomer 351;3eta1017-1310
Assess
Solution structure of the transmembrane domain of the insulin receptor in micellesmonomer 2mfr940-988
Assess

Homology models built on isoform sequence

IsoformOligo-stateLigandsQMEANTemplateRangeSeq id (%)
Isoform 2monomer-0.841mp8.1.A1003-1282
39.55
Assess
Isoform 2monomer-3.957bwa.1.A32-840
100.00
Assess
Isoform 2monomer-3.516jk8.1.A33-938
59.59
Assess
Isoform 2monomerNAG;-4.876jk8.1.B33-935
59.59
Assess